Subscribe to RSS
DOI: 10.1055/s-0029-1217521
Stereoselective Construction of Steroidal Side Chain from 16-Dehydropregnenolone Acetate
Publication History
Publication Date:
01 July 2009 (online)
Abstract
Stereoselective construction of steroidal side chain at C-20 having ‘natural’ configuration using 16-dehydropregnalone acetate (16-DPA) as a starting material has been carried out. Palladium-catalyzed carbon-carbon bond-forming Heck reaction between C-20 vinyl iodide with methyl acrylate and transfer hydrogenation with triethylsilane and Pd/C are the key steps for stereoselective side-chain synthesis.
Key words
stereoselectivity - 16-dehydropregnenolone acetate - Heck coupling - transfer hydrogenation - steroidal side chain
The introduction of the properly functionalized side chains onto tetracyclic steroidal starting materials has been the subject matter of several investigations. [¹] [²] Most of the naturally occurring steroids isolated from plant, marine, and animal sources have the C(20R) stereochemistry, for example, cholesterol (1), brassinolide (2), [³] squalamine (3), [4] OSW-1 (4), [5] vitamin D3 (5) [6] (Figure [¹] ) and many other biologically important steroids with modified side chains such as ecdysones, [7] contignasterol, [8] and marine sterols. [9] Due to high biological activity of single isomer and their scarcity from natural resources, methods for their stereoselective synthesis are highly desirable.
Synthetic methods for stereoselective construction of steroidal side chain have involved the use of Michael addition, [¹0] palladium-catalyzed reactions, [¹¹] alkylation at C-20, [¹²] Claisen sigmatropic rearrangement, [¹³] ene reaction, [¹4] Wittig rearrangement, [¹5] aldol condensation, [¹6] use of organoborane, [¹7] organozirconium [¹8] and organoruthenium [¹9] reagents, etc. The focal point of any such synthesis is the stereospecific introduction of the asymmetric center at C-20.
Catalytic hydrogenation of double bonds formed between C-20 and one of the adjacent carbons at C-17 and C-21 or C-22 is one of the most attractive methods for introduction of chiral centre at C-20. Hydrogenation of the 20(21)/20(22) by using different catalysts affording the C-20 epimeric mixture has been reported. [¹a] Construction of side chain by Wittig reaction on C-20 oxo steroids followed by selective hydrogenation is the simplest and most versatile method. Hydrogenation of C-20(22) double bond using different catalysts such as H2 Pd/C, Pt/C, Ra-Ni (W-2), (Ph3P)3RhCl, 5% Rh/Al2O3 afforded the C-20 epimeric mixture, [²0] while hydrogenation using PtO2 in EtOH showed better selectivity. [²¹] Older literature reports showed inconsistency in selectivity using PtO2 catalyst. [¹a] [²0a] The C-22 furan derivative of pregnenolone acetate having C-20(21) double bond, on hydrogenation using H2 and Pd/C in benzene afforded the compound having C-(20R) natural stereochemistry. [²²] There is a recent report on introduction of side chain on the estrane skeleton in which hydrogenation using Pd/C gave a mixture of C-20(R) and C-20(S) compounds in a 7:3 ratio. [²³]

Figure 1 Natural steroids having C-(20R) configuration
In continuation of our interest in stereoselecive construction of steroidal side chain, [¹4c-e] we recently developed new methods for a highly stereoselective synthesis of unnatural C-20(R)-aldehydes starting from 16-dehydropregnenolone acetate (16-DPA) by ionic hydrogenation of C-20(22)-ketene dithioacetal [²4a] and C-20 tertiary alcohols. [²4b] These aldehydes were used for the synthesis of 20-epicholanic acid derivatives. [²4c] In this paper we wish to report a short route for stereoselective synthesis of C-20(R) cholanic acid derivative from 16-DPA (6). Palladium-catalyzed Heck coupling of C-20 vinyl iodide compound 9 with methyl acrylate and Pd/C-induced catalytic transfer hydrogenation with triethylsilane are the key steps in this synthesis.
Chemoselective catalytic hydrogenation of C-16 double bond of 16-DPA (6) with 10% Pd/C in ethyl acetate resulted into saturated ketone 7 in 98% yield [²4c] (Scheme [¹] ). The ¹H NMR spectrum of this compound showed chemical shifts of δ = 0.63 (s, 3 H, 18-CH3) and 2.13 (s, 3 H, 21-CH3) ppm. Reaction of 7 with hydrazine hydrate in MeOH afforded C-20 hydrazone product 8 in almost quantitative yield. This compound 8 showed characteristic up field chemical shift of δ = 0.59 (s, 3 H, 18-CH3) and 1.76 (s, 3 H, 21-CH3) ppm in comparison with compound 7. In the ¹³C NMR spectrum quaternary carbon (C-20 hydrazone) was observed at δ = 151.5 ppm. Oxidation of hydrazone was carried out using iodine in the presence of organic base, triethylamine, to give vinyl iodide 9 in good yield. [²5] In the ¹H NMR spectrum of compound 9 the geminal C-21 methylene protons showed different chemical shifts [δ = 5.98 (d, J = 1.51 Hz, 1 H) and 6.15 (br s, 1 H) ppm]. In the ¹³C NMR spectrum methylene at C-21 was observed at δ = 126.1 ppm. There are reports in the literature on palladium-catalyzed carbon-carbon bond-forming reactions of steroidal vinyl iodide or vinyl triflate with alkenes and terminal alkynes. [²6]

Scheme 1 Reagents and conditions: a) 10% Pd/C, H2, EtOAc, 3.1 bar, 25-30 ˚C, 12 h, 98%; b) hydazine hydrate, Et3N, MeOH, 25-30 ˚C, 4 h, 98%; c) I2, Et3N, THF, 25-30 ˚C, 3 h, 74%; d) Pd(OAc)2 (0.04%) K2CO3, methyl acrylate, DMF, 25-30 ˚C, 12 h, 77%; e) 10% Pd/C (15% by weight), MeOH, TES (excess), 10 min; f) H2, Pd/C, EtOAc, 3.1 bar, 30 ˚C, 10 h (overall 90% after two steps; ratio of 12a/12b = 8:2).
Heck coupling of steroidal vinyl iodides at C-17, with allyl acetates or methyl acrylate in the presence of catalytic amount of Pd(OAc)2 and triethyl amine or K2CO3 at 60-100 ˚C, is known in the literature. [²7] When we carried out coupling reaction of C-20 vinyl iodide 9 with methyl acrylate using the literature procedure, [²7] afforded the complex mixture of products which could not be identified. However, when the same reaction was carried out using catalytic amount of Pd(OAc)2 and K2CO3 in DMF at 25-30 ˚C, 80% conversion of starting material was observed (on the basis of recovered starting material) and expected product 10 was obtained as a single product. [²8] Increase in amount of the catalyst or extended reaction time did not improve the complete conversion of the starting material into the product. Use of Pd(PPh3)4 resulted in 45% conversion while addition of Pd(OAc)2 and Ph3P as catalysts resulted in the complete conversion of starting material but the expected product 10 was isolated in poor yield along with many unidentified products. The IR spectrum of 10 showed bands at 1724 and 1668 cm-¹ for C-3 acetate carbonyl and C-24 methyl ester carbonyl respectively. Its ¹H NMR spectrum showed characteristic signals at δ = 5.34 and 5.55 ppm as two singlets for C-21-CH2 and δ = 6.02 (d, 1 H, J = 15.95 Hz), 7.36 (d, 1 H, J = 15.95 Hz) ppm for C-23 and C-22 CH, respectively. In the ¹³C NMR spectrum C-24 carbonyl was observed at δ = 167.6 ppm and C-21-CH2 at δ = 122 ppm.
Our next goal was to obtain single C-20(R) isomer by stereoselective hydrogenation of C-20(21) double bond. Catalytic hydrogenation of 10 on Pd/C in ethyl acetate at 3.1 bar for 10 hours afforded the epimeric mixture 12a and 12b in the ratio of 6:4. Recently, there is a report [²9] on Pd/C-induced catalytic transfer hydrogenation using triethylsilane to give efficient reduction of multiple bonds, azides, imines, and nitro groups as well as benzyl and allyl group deprotection, under mild neutral conditions. Transfer hydrogenation [²9] of compound 10 using catalytic amount of 10% Pd/C and excess of triethylsilane in MeOH afforded compounds 11a,b and 12a,b as an epimeric mixture at C-20 in 10 minutes. Various attempts of purification of this mixture and to determine the ratio of the products obtained did not fructify. In ¹H NMR of this mixture (Figure [²] ), C-20(21) double bond was observed to be completely hydrogenated (disappearance of chemical shift at δ = 5.34 and 5.55 ppm while C-22(23) double bond was partially hydrogenated and 5(6) double bond remained unaffected. The major chemical shifts in the ¹H NMR spectrum of this mixture (Figure [²] ) were found to be at δ = 6.90 (dd, 1 H, J = 10, 16 Hz, C-22H) and 5.73 (d, 1 H, J = 16 Hz, C-23H), 1.09 (d, 3 H, J = 6.57 Hz, C-21CH3) ppm. These chemical shifts matches with the literature values [³0] of compound 11a having C-20(R) natural stereochemistry.

Figure 2 ¹H NMR of epimeric mixture of 11a,b and 12a,b
For complete conversion of 11a,b into 12a,b further hydrogenation of this mixture was carried out using H2 and Pd/C in EtOAc. It gave C-20 epimeric mixture of compounds 12a and 12b in 8:2 ratio [³¹] (calculated by ¹H NMR chemical shift of methyl ester and C-21 methyl protons as shown in Figure [³] ). In the ¹H NMR spectrum of the mixture of compounds 12a,b (Figure [³] ) major peaks were observed at δ = 0.67 (s, 3 H, 18-CH3), 0.92 (d, 3 H, J = 6.33 Hz, 21-CH3), 3.67 (s, 3 H, COOCH3) ppm while minor peaks observed at δ = 0.69 (s, 3 H, 18-CH3), 0.85 (d, 3 H, J = 6.33 Hz, 21-CH3), 3.69 (s, 3 H, COOCH3). These chemical shifts match with the literature data [³0] of compounds 12a and 12b having C-20(R)- and C-20(S) configuration, respectively. The mixture of compounds 12a and 12b was purified by crystallization in CH2Cl2-MeOH (1:9) to get pure cholanic acid derivative 12a in 62% yield as a major compound.

Figure 3 ¹H NMR of epimeric mixture of 12a and 12b
The stereochemistry of compound 12a at C-20 was finally confirmed by single crystal X-ray diffraction (Figure [4] ). [³¹] [³²]

Figure 4 ORTEP view of methyl (20R)-3β-acetoxychol-5-enoate 12a
From the mother liquor compound 12b was isolated in 8% yield after several crystallizations. Cholanic acid derivatives with natural configuration at C-20 are important compounds for an investigation of the biological fat of cholesterol and for the treatment of gallstones. They are also key intermediates for the synthesis of large number of biologically active steroids having natural C-20(R) configuration.
In conclusion, stereoselective construction of steroidal side chain at C-20 position having ‘natural’ C-20(R) configuration from 20 oxo steroid (16-DPA) (6) has been achieved. Palladium-catalyzed carbon-carbon bond-forming Heck reaction has been used for coupling between C-20 vinyl iodide 9 and methyl acrylate to form unsaturated compound 10. Transfer hydrogenation using triethylsilane and Pd/C is the key step for stereoselective side-chain synthesis.
Acknowledgment
VSP thanks Director, NCL, for In-House funding (MLP 13126). NGA thanks CSIR-UGC, New Delhi, for the award of Junior Research Fellowship.
- 1a For
a review on the construction of steroid side chain, see:
Piatak DM.Wicha J. Chem. Rev. 1978, 78: 199 - 1b
Redpath J.Zeelan F. Chem. Soc. Rev. 1983, 12: 75 - 2a
Ibuka T.Taga T.Shingu T.Saito M.Nishii S.Yamamoto Y. J. Org. Chem. 1988, 53: 3947 - 2b
He Z.Yi CS.Donaldson WA. Org. Lett. 2003, 5: 1567 ; and references cited therein - 2c
Harada S.Kiyono H.Nishio R.Tagushi T.Hanzawa Y. J. Org. Chem. 1997, 62: 3994 - 3a
Adam G.Marquardt V. Phytochemistry 1986, 25: 1787 - 3b
Lokhvich FA.Khripach VA.Zhabinskii VN. Russ. Chem. Rev. 1991, 60: 658 - 3c
Kovganko NV.Ananich SK. Chem. Nat. Compd. 2002, 38: 122 - 3d
Massey AP.Pore VS.Hazra BG. Synthesis 2003, 426 - 3e
Ramirez JA.Brosa C.Galagovsky LR. Phytochemistry 2005, 66: 581 - 4a
Brunel JM.Letourneux Y. Eur. J. Org. Chem. 2003, 3897 ; and references cited therein - 4b
Zhang DH.Cai F.Zhou X.-D.Zhou W.-S. Org. Lett. 2003, 5: 3257 - 4c
Okumura K.Nakamura Y.Takeuchi S.Kato I.Fujimoto Y.Ikekawa N. Chem. Pharm. Bull. 2003, 51: 1177 - 4d
Zhang D.-H.Cai F.Zhou X.-D.Zhou W.-S. Chin. J. Chem. 2005, 23: 176 - 5
Morzycki JW.Wojtkielewicz A. Phytochem. Rev. 2005, 4: 259 ; and references cited therein - 6a
Georghiou PE. Chem. Soc. Rev. 1977, 6: 83 - 6b
Taber DF.Jiang Q.Chen B.Zhang W.Campbell CL. J. Org. Chem. 2002, 67: 4821 - 6c
Gorobets E.Stepanenko V.Wicha J. Eur. J. Org. Chem. 2004, 783 - 7a
Nakanishi K. Pure Appl. Chem. 1971, 25: 167 - 7b
Kovganko NV.Kashkan ZhN.Chernov YG.Ananich SK.Sokolov SN.Survilo VL. Chem. Nat. Compd. 2003, 39: 411 - 8a
Burgoyne DL.Andersen RJ.Allen TM. J. Org. Chem. 1992, 57: 525 - 8b
Izzo I.Avallone E.Monica CD.Casapullo A.Amigo M.Riccardis D. Tetrahedron 2004, 60: 5587 - 9a
Nes WR.Mckean ML. Biochemistry of Steroids and other Isoprenoids University Park; Baltimore MD: 1977. - 9b
D’Aura MV.Minale L.Ricco R. Chem. Rev. 1993, 93: 1839 - 9c
Stonik VA. Russ. Chem. Rev. 2001, 70: 673 - 10a
Yu W.Jin Z. J. Am. Chem. Soc. 2001, 123: 3369 - 10b
Yu W.Jin Z. J. Am. Chem. Soc. 2002, 124: 6576 - 11a
Mandai T.Matsumoto T.Kawada M.Tsuji J. J. Org. Chem. 1992, 57: 6090 - 11b
Mandai T.Matsumoto T.Kawada M.Tsuji J. Tetrahedron 1999, 50: 475 - 12a
Kurek-Tyrlik A.Michalak K.Urbanczyk-Lipkowska Z.Wicha J. Tetrahedron Lett. 2004, 45: 7479 - 12b
Kurek-Tyrlik A.Michalak K.Wicha J. J. Org. Chem. 2005, 70: 8513 - 13a
Tanabe M.Hayashi K. J. Am. Chem. Soc. 1980, 102: 862 - 13b
Mikami K.Kawamoto K.Nakai T. Tetrahedron Lett. 1986, 27: 4899 - 14a
Yamamoto S.Watanabe B.Otsuki J.Nakagawa Y.Akamatsu M.Miyagawa H. Bioorg. Med. Chem. 2006, 14: 1761 - 14b
Houston TA.Tanaka Y.Koreeda M. J. Org. Chem. 1993, 58: 4287 - 14c
Hazra BG.Joshi PL.Pore VS. Tetrahedron Lett. 1990, 31: 6227 - 14d
Hazra BG.Pore VS.Joshi PL. J. Chem. Soc., Perkin Trans. 1 1993, 1819 - 14e
Hazra BG.Joshi PL.Bahule BB.Argade NP.Pore VS.Chordia MD. Tetrahedron 1994, 50: 2523 - 15a
Nakai T.Mikami K. Chem. Rev. 1986, 86: 885 - 15b
Castedo L.Granja JR.Mouriño A. Tetrahedron Lett. 1985, 26: 4959 - 16a
Shi B.Wu H.Yu B.Wu J. Angew. Chem. Int. Ed. 2004, 43: 4324 - 16b
Shi B.Tang P.Hu X.Liu JO.Yu B. J. Org. Chem. 2005, 70: 10354 - 17
Katoch R.Korde SS.Deodhar KD.Trivedi GK. Tetrahedron 1999, 55: 1741 - 18a
Temple JS.Riediker M.Schwartz J. J. Am. Chem. Soc. 1982, 104: 1310 - 18b
Harada S.Kiyono H.Nishio R.Taguchi T.Hanzawa Y.Shiro M. J. Org. Chem. 1997, 62: 3994 - 19
He Z.Yi CS.Donaldson WA. Org. Lett. 2003, 5: 1567 - 20a
DuBois GE. J. Org. Chem. 1982, 47: 5035 - 20b
Kametani T.Katoh T.Fujio J.Nogiwa I.Tsubuki M.Toshio Honda T. J. Org. Chem. 1988, 53: 1982 - 21
Fukumoto K.Suzuki K.Nemoto H.Kametani T.Furuyama H. Tetrahedron 1982, 38: 3701 - 22a
Kametani T.Masayoshi T.Nemoto H. Tetrahedron Lett. 1981, 22: 2373 - 22b
Kametani T.Suzuki K.Nemoto H. J. Org. Chem. 1982, 47: 2331 - 23
Jogireddy R.Rullkotter J.Christoffers J. Synlett 2007, 2847 - 24a
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Chem. Commun. 2004, 2194 - 24b
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Tetrahedron Lett. 2006, 47: 9343 - 24c
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Tetrahedron 2007, 63: 5622 - 25a
Barton DHR.O’Brien RE.Sternhell S. J. Chem. Soc. 1962, 470 - 25b
Barton DHR.Bashiardes G.Fourrey J.-L. Tetrahedron Lett. 1983, 24: 1605 - 25c
Barton DHR.Bashiardes G.Fourrey J.-L. Tetrahedron 1988, 44: 147 - 26
Skoda-Földes R.Kollár L. Chem. Rev. 2003, 103: 4095 - 27
Skoda-Földes R.Bodnar M.Kollár L.Horvath J.Tuba Z. Steroids 1998, 63: 93 - 29
Mandal PK.McMurray JS. J. Org. Chem. 2007, 72: 6599 - 30
Vanderah DJ.Djerassi C. J. Org. Chem. 1978, 43: 1442
References and Notes
Methyl [20 (21),22]-3β-Acetoxychol-5-trienoate (10) To a solution of vinyl iodide 9 (0.234 g, 0.5 mmol) in dry DMF (10 mL), methyl acrylate (0.9 mL 1 mmol), Pd catalyst (0.005 g, 0.02 mmol), and K2CO3 (0.414 g, 1.5 mmol) were added, and the reaction mixture was stirred under argon at 25-28 ˚C for 12 h. Ice was added to the reaction mixture, and it was extracted with EtOAc (3 × 25 mL). The extract was washed 5% HCI (2 × 25 mL), sat. aq NaHCO3 (20 mL) and brine, and dried over Na2SO4. The product was purified by chromatography on silica gel (2% EtOAc-PE) to give pure product 10 (0.163 g) in 77% yield and starting material 9 (0.047 g). Colorless solid; mp 93-94 ˚C; [α]D ²6 -32.0 (c 2.58, CHCl3); IR (mull): 1691, 1724 cm-¹. ¹H NMR (200 MHz, CDCl3): δ = 0.56 (s, 3 H, 18-CH3), 1.02 (s, 3 H, 19-CH3), 2.04 (s, 3 H, OCOCH3), 3.76 (s, 3 H, COOCH3), 4.61 (m, 1 H, 3-CH), 5.34 (s, 1 H, 21-CH2), 5.38 (d, J = 5.0 Hz, 1 H, 6-CH), 5.55 (s, 1 H, 21-CH2), 6.02 (d, J = 16.0 Hz, 1 H, 23-CH), 7.36 (d, J = 16.0 Hz, 1 H, 22-CH). ¹³C NMR (50 MHz, CDCl3): δ = 12.8, 19.2, 20.9, 21.3, 24.2, 26.3, 27.6, 31.7, 32.3, 36.5, 36.9, 38.0, 38.6, 43.2, 50.0, 51.1, 51.5, 56.6, 73.8, 117.3, 122.0, 122.3, 139.6, 144.0, 149.1, 167.6, 170.4. Anal. Calcd for C27H38O4: C, 76.02; H, 8.98. Found: C, 75.79; H, 8.78. ESI-LCMS: m/z = 427.58 [M+ + 1].
31
Hydrogenation
of Compound 10
To a stirred solution of compound 10 (0.100 g 0.24 mmol) in MeOH (4 mL) 10% Pd/C
(0.015 g, 15% by weight) was added under an argon-filled
balloon. Neat TES (0.4 mL, 2.4 mmol) was added dropwise to the reaction
mixture. Within 10 min the reaction was complete. The reaction mixture
was filtered through Celite, and the solvent was removed under vacuum.
The product was purified by column chromatography on silica gel
(2% EtOAc-hexane) to furnish a mixture of compounds 11a,b and 12a,b (0.094 g). Catalytic
hydrogenation of this mixture (0.094 g) was carried out using 10% Pd/C
(0.009 g) at 3.1 bar, in 10 mL EtOAc at 30 ˚C for 10 h.
The reaction mixture was filtered through Celite, and the filtrate
was evaporated under reduced pressure to obtain diastereomeric mixture
of 12a/12b (0.091 g)
in 90% yield (Overall after 2 steps). Crystallization of
the crude product from 10 mL MeOH-CH2Cl2 (9:1)
gave major product C-20 (R)-ol, 12a (0.063 g) in 62% yield and
after several crystallization minor product C-20 (R)-ol 12b (0.008 g) in 8% yield.
Methyl (20
R
)-3β-Acetoxychol-5-en-24-oate (12a)
Colorless
solid; mp 160-162 ˚C; [α]D
²6 (CHCl3, c 2.0) -46.0. IR (mull): 1724
cm-¹. ¹H NMR (200
MHz, CDCl3): δ = 0.67 (s, 3 H, 18-CH3),
0.92 (d, J = 6.3
Hz, 3 H, 21-CH3), 1.01 (s, 3 H, 19-CH3), 2.03
(s, 3 H, OCOCH3), 3.66 (s, 3 H, COOCH3), 4.60
(m, 1 H, 3-CH), 5.36 (d, J = 5.0
Hz, 1 H, 6-CH). ¹³C NMR (50 MHz, CDCl3): δ = 11.8,
18.3, 19.3, 21.0, 21.4, 24.2, 27.7, 28.1, 31.0, 31.0, 31.8, 31.9,
35.3, 36.5, 37.0, 38.1, 39.7, 42.3, 50.0, 51.4, 55.7, 56.6, 73.9,
122.5, 139.6, 170.4, 174.7. Anal. Calcd for C27H42O4:
C, 75.31; H, 9.83. Found: C, 75.27; H, 9.71. ESI-LCMS: m/z = 431.62 [M+ + 1].
Crystallographic
Data for Compound 12a
Empirical formula: C27H42O4;
formula weight: 430.61, temp, 297 (2) K, wavelength, 0.71073 A;
crystal system; space group, monoclinic, P21; unit cell dimensions, a = 11.0178 (18)
A, α = 90˚, β = 7.4633
(13) A, β = 92.080 (3)˚, c = 14.950
(3) A, γ = 90˚; volume,
1228.5 (4) A³, Z; calcd density, 2, 1.164 mg/m³;
absorption coefficient, 0.076 mm-¹, F(000) 472; crystal size, 0.40 × 0.29 × 0.03
mm; θ range for data collection 1.36-25.99˚;
limiting indices, -13< = h< = 13, -9< = k< = 9, -18< = l < = 17,
reflections collected/unique 9650/4755 [R(int) = 0.0275];
completeness to θ = 25.99, 99.9%;
absorption correction, semi-empirical from equivalents; max. and
min. transmission 0.9977 and 0.9702; refinement method, full-matrix
least-squares on F²; data/restraints/ arameters,
4755/1/285; goodness-of-fit on F²,
1.182; final R indices [I > 2σ(I)] R1 = 0.0655, wR2 = 0.1285, R indices (all data), R1 = 0.0784, wR2 = 0.1346;
largest diff. peak and hole, 0.194 and -0.174 e A-³.
CCDC 725609 contains the supplementary crystallographic data for
this structure. These data can be obtained free of charge from the
Cambridge Crystallo-graphic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Methyl (20
S
)-3β-Acetoxychol-5-en-24-oate (12b)
Colorless solid; mp 120-121 ˚C. ¹H
NMR (200 MHz, CDCl3): δ = 0.69 (s,
3 H, 18-CH3), 0.85 (d, J = 4.0
Hz, 3 H, 21-CH3), 1.02 (s, 3 H, 19-CH3), 2.03
(s, 3 H, OCOCH3), 3.67 (s, 3 H, COOCH3), 4.63
(m, 1 H, 3-CH), 5.38 (d, J = 5.0
Hz, 1 H, 6-CH).
- 1a For
a review on the construction of steroid side chain, see:
Piatak DM.Wicha J. Chem. Rev. 1978, 78: 199 - 1b
Redpath J.Zeelan F. Chem. Soc. Rev. 1983, 12: 75 - 2a
Ibuka T.Taga T.Shingu T.Saito M.Nishii S.Yamamoto Y. J. Org. Chem. 1988, 53: 3947 - 2b
He Z.Yi CS.Donaldson WA. Org. Lett. 2003, 5: 1567 ; and references cited therein - 2c
Harada S.Kiyono H.Nishio R.Tagushi T.Hanzawa Y. J. Org. Chem. 1997, 62: 3994 - 3a
Adam G.Marquardt V. Phytochemistry 1986, 25: 1787 - 3b
Lokhvich FA.Khripach VA.Zhabinskii VN. Russ. Chem. Rev. 1991, 60: 658 - 3c
Kovganko NV.Ananich SK. Chem. Nat. Compd. 2002, 38: 122 - 3d
Massey AP.Pore VS.Hazra BG. Synthesis 2003, 426 - 3e
Ramirez JA.Brosa C.Galagovsky LR. Phytochemistry 2005, 66: 581 - 4a
Brunel JM.Letourneux Y. Eur. J. Org. Chem. 2003, 3897 ; and references cited therein - 4b
Zhang DH.Cai F.Zhou X.-D.Zhou W.-S. Org. Lett. 2003, 5: 3257 - 4c
Okumura K.Nakamura Y.Takeuchi S.Kato I.Fujimoto Y.Ikekawa N. Chem. Pharm. Bull. 2003, 51: 1177 - 4d
Zhang D.-H.Cai F.Zhou X.-D.Zhou W.-S. Chin. J. Chem. 2005, 23: 176 - 5
Morzycki JW.Wojtkielewicz A. Phytochem. Rev. 2005, 4: 259 ; and references cited therein - 6a
Georghiou PE. Chem. Soc. Rev. 1977, 6: 83 - 6b
Taber DF.Jiang Q.Chen B.Zhang W.Campbell CL. J. Org. Chem. 2002, 67: 4821 - 6c
Gorobets E.Stepanenko V.Wicha J. Eur. J. Org. Chem. 2004, 783 - 7a
Nakanishi K. Pure Appl. Chem. 1971, 25: 167 - 7b
Kovganko NV.Kashkan ZhN.Chernov YG.Ananich SK.Sokolov SN.Survilo VL. Chem. Nat. Compd. 2003, 39: 411 - 8a
Burgoyne DL.Andersen RJ.Allen TM. J. Org. Chem. 1992, 57: 525 - 8b
Izzo I.Avallone E.Monica CD.Casapullo A.Amigo M.Riccardis D. Tetrahedron 2004, 60: 5587 - 9a
Nes WR.Mckean ML. Biochemistry of Steroids and other Isoprenoids University Park; Baltimore MD: 1977. - 9b
D’Aura MV.Minale L.Ricco R. Chem. Rev. 1993, 93: 1839 - 9c
Stonik VA. Russ. Chem. Rev. 2001, 70: 673 - 10a
Yu W.Jin Z. J. Am. Chem. Soc. 2001, 123: 3369 - 10b
Yu W.Jin Z. J. Am. Chem. Soc. 2002, 124: 6576 - 11a
Mandai T.Matsumoto T.Kawada M.Tsuji J. J. Org. Chem. 1992, 57: 6090 - 11b
Mandai T.Matsumoto T.Kawada M.Tsuji J. Tetrahedron 1999, 50: 475 - 12a
Kurek-Tyrlik A.Michalak K.Urbanczyk-Lipkowska Z.Wicha J. Tetrahedron Lett. 2004, 45: 7479 - 12b
Kurek-Tyrlik A.Michalak K.Wicha J. J. Org. Chem. 2005, 70: 8513 - 13a
Tanabe M.Hayashi K. J. Am. Chem. Soc. 1980, 102: 862 - 13b
Mikami K.Kawamoto K.Nakai T. Tetrahedron Lett. 1986, 27: 4899 - 14a
Yamamoto S.Watanabe B.Otsuki J.Nakagawa Y.Akamatsu M.Miyagawa H. Bioorg. Med. Chem. 2006, 14: 1761 - 14b
Houston TA.Tanaka Y.Koreeda M. J. Org. Chem. 1993, 58: 4287 - 14c
Hazra BG.Joshi PL.Pore VS. Tetrahedron Lett. 1990, 31: 6227 - 14d
Hazra BG.Pore VS.Joshi PL. J. Chem. Soc., Perkin Trans. 1 1993, 1819 - 14e
Hazra BG.Joshi PL.Bahule BB.Argade NP.Pore VS.Chordia MD. Tetrahedron 1994, 50: 2523 - 15a
Nakai T.Mikami K. Chem. Rev. 1986, 86: 885 - 15b
Castedo L.Granja JR.Mouriño A. Tetrahedron Lett. 1985, 26: 4959 - 16a
Shi B.Wu H.Yu B.Wu J. Angew. Chem. Int. Ed. 2004, 43: 4324 - 16b
Shi B.Tang P.Hu X.Liu JO.Yu B. J. Org. Chem. 2005, 70: 10354 - 17
Katoch R.Korde SS.Deodhar KD.Trivedi GK. Tetrahedron 1999, 55: 1741 - 18a
Temple JS.Riediker M.Schwartz J. J. Am. Chem. Soc. 1982, 104: 1310 - 18b
Harada S.Kiyono H.Nishio R.Taguchi T.Hanzawa Y.Shiro M. J. Org. Chem. 1997, 62: 3994 - 19
He Z.Yi CS.Donaldson WA. Org. Lett. 2003, 5: 1567 - 20a
DuBois GE. J. Org. Chem. 1982, 47: 5035 - 20b
Kametani T.Katoh T.Fujio J.Nogiwa I.Tsubuki M.Toshio Honda T. J. Org. Chem. 1988, 53: 1982 - 21
Fukumoto K.Suzuki K.Nemoto H.Kametani T.Furuyama H. Tetrahedron 1982, 38: 3701 - 22a
Kametani T.Masayoshi T.Nemoto H. Tetrahedron Lett. 1981, 22: 2373 - 22b
Kametani T.Suzuki K.Nemoto H. J. Org. Chem. 1982, 47: 2331 - 23
Jogireddy R.Rullkotter J.Christoffers J. Synlett 2007, 2847 - 24a
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Chem. Commun. 2004, 2194 - 24b
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Tetrahedron Lett. 2006, 47: 9343 - 24c
Shingate BB.Hazra BG.Pore VS.Gonnade RG.Bhadbhade MM. Tetrahedron 2007, 63: 5622 - 25a
Barton DHR.O’Brien RE.Sternhell S. J. Chem. Soc. 1962, 470 - 25b
Barton DHR.Bashiardes G.Fourrey J.-L. Tetrahedron Lett. 1983, 24: 1605 - 25c
Barton DHR.Bashiardes G.Fourrey J.-L. Tetrahedron 1988, 44: 147 - 26
Skoda-Földes R.Kollár L. Chem. Rev. 2003, 103: 4095 - 27
Skoda-Földes R.Bodnar M.Kollár L.Horvath J.Tuba Z. Steroids 1998, 63: 93 - 29
Mandal PK.McMurray JS. J. Org. Chem. 2007, 72: 6599 - 30
Vanderah DJ.Djerassi C. J. Org. Chem. 1978, 43: 1442
References and Notes
Methyl [20 (21),22]-3β-Acetoxychol-5-trienoate (10) To a solution of vinyl iodide 9 (0.234 g, 0.5 mmol) in dry DMF (10 mL), methyl acrylate (0.9 mL 1 mmol), Pd catalyst (0.005 g, 0.02 mmol), and K2CO3 (0.414 g, 1.5 mmol) were added, and the reaction mixture was stirred under argon at 25-28 ˚C for 12 h. Ice was added to the reaction mixture, and it was extracted with EtOAc (3 × 25 mL). The extract was washed 5% HCI (2 × 25 mL), sat. aq NaHCO3 (20 mL) and brine, and dried over Na2SO4. The product was purified by chromatography on silica gel (2% EtOAc-PE) to give pure product 10 (0.163 g) in 77% yield and starting material 9 (0.047 g). Colorless solid; mp 93-94 ˚C; [α]D ²6 -32.0 (c 2.58, CHCl3); IR (mull): 1691, 1724 cm-¹. ¹H NMR (200 MHz, CDCl3): δ = 0.56 (s, 3 H, 18-CH3), 1.02 (s, 3 H, 19-CH3), 2.04 (s, 3 H, OCOCH3), 3.76 (s, 3 H, COOCH3), 4.61 (m, 1 H, 3-CH), 5.34 (s, 1 H, 21-CH2), 5.38 (d, J = 5.0 Hz, 1 H, 6-CH), 5.55 (s, 1 H, 21-CH2), 6.02 (d, J = 16.0 Hz, 1 H, 23-CH), 7.36 (d, J = 16.0 Hz, 1 H, 22-CH). ¹³C NMR (50 MHz, CDCl3): δ = 12.8, 19.2, 20.9, 21.3, 24.2, 26.3, 27.6, 31.7, 32.3, 36.5, 36.9, 38.0, 38.6, 43.2, 50.0, 51.1, 51.5, 56.6, 73.8, 117.3, 122.0, 122.3, 139.6, 144.0, 149.1, 167.6, 170.4. Anal. Calcd for C27H38O4: C, 76.02; H, 8.98. Found: C, 75.79; H, 8.78. ESI-LCMS: m/z = 427.58 [M+ + 1].
31
Hydrogenation
of Compound 10
To a stirred solution of compound 10 (0.100 g 0.24 mmol) in MeOH (4 mL) 10% Pd/C
(0.015 g, 15% by weight) was added under an argon-filled
balloon. Neat TES (0.4 mL, 2.4 mmol) was added dropwise to the reaction
mixture. Within 10 min the reaction was complete. The reaction mixture
was filtered through Celite, and the solvent was removed under vacuum.
The product was purified by column chromatography on silica gel
(2% EtOAc-hexane) to furnish a mixture of compounds 11a,b and 12a,b (0.094 g). Catalytic
hydrogenation of this mixture (0.094 g) was carried out using 10% Pd/C
(0.009 g) at 3.1 bar, in 10 mL EtOAc at 30 ˚C for 10 h.
The reaction mixture was filtered through Celite, and the filtrate
was evaporated under reduced pressure to obtain diastereomeric mixture
of 12a/12b (0.091 g)
in 90% yield (Overall after 2 steps). Crystallization of
the crude product from 10 mL MeOH-CH2Cl2 (9:1)
gave major product C-20 (R)-ol, 12a (0.063 g) in 62% yield and
after several crystallization minor product C-20 (R)-ol 12b (0.008 g) in 8% yield.
Methyl (20
R
)-3β-Acetoxychol-5-en-24-oate (12a)
Colorless
solid; mp 160-162 ˚C; [α]D
²6 (CHCl3, c 2.0) -46.0. IR (mull): 1724
cm-¹. ¹H NMR (200
MHz, CDCl3): δ = 0.67 (s, 3 H, 18-CH3),
0.92 (d, J = 6.3
Hz, 3 H, 21-CH3), 1.01 (s, 3 H, 19-CH3), 2.03
(s, 3 H, OCOCH3), 3.66 (s, 3 H, COOCH3), 4.60
(m, 1 H, 3-CH), 5.36 (d, J = 5.0
Hz, 1 H, 6-CH). ¹³C NMR (50 MHz, CDCl3): δ = 11.8,
18.3, 19.3, 21.0, 21.4, 24.2, 27.7, 28.1, 31.0, 31.0, 31.8, 31.9,
35.3, 36.5, 37.0, 38.1, 39.7, 42.3, 50.0, 51.4, 55.7, 56.6, 73.9,
122.5, 139.6, 170.4, 174.7. Anal. Calcd for C27H42O4:
C, 75.31; H, 9.83. Found: C, 75.27; H, 9.71. ESI-LCMS: m/z = 431.62 [M+ + 1].
Crystallographic
Data for Compound 12a
Empirical formula: C27H42O4;
formula weight: 430.61, temp, 297 (2) K, wavelength, 0.71073 A;
crystal system; space group, monoclinic, P21; unit cell dimensions, a = 11.0178 (18)
A, α = 90˚, β = 7.4633
(13) A, β = 92.080 (3)˚, c = 14.950
(3) A, γ = 90˚; volume,
1228.5 (4) A³, Z; calcd density, 2, 1.164 mg/m³;
absorption coefficient, 0.076 mm-¹, F(000) 472; crystal size, 0.40 × 0.29 × 0.03
mm; θ range for data collection 1.36-25.99˚;
limiting indices, -13< = h< = 13, -9< = k< = 9, -18< = l < = 17,
reflections collected/unique 9650/4755 [R(int) = 0.0275];
completeness to θ = 25.99, 99.9%;
absorption correction, semi-empirical from equivalents; max. and
min. transmission 0.9977 and 0.9702; refinement method, full-matrix
least-squares on F²; data/restraints/ arameters,
4755/1/285; goodness-of-fit on F²,
1.182; final R indices [I > 2σ(I)] R1 = 0.0655, wR2 = 0.1285, R indices (all data), R1 = 0.0784, wR2 = 0.1346;
largest diff. peak and hole, 0.194 and -0.174 e A-³.
CCDC 725609 contains the supplementary crystallographic data for
this structure. These data can be obtained free of charge from the
Cambridge Crystallo-graphic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Methyl (20
S
)-3β-Acetoxychol-5-en-24-oate (12b)
Colorless solid; mp 120-121 ˚C. ¹H
NMR (200 MHz, CDCl3): δ = 0.69 (s,
3 H, 18-CH3), 0.85 (d, J = 4.0
Hz, 3 H, 21-CH3), 1.02 (s, 3 H, 19-CH3), 2.03
(s, 3 H, OCOCH3), 3.67 (s, 3 H, COOCH3), 4.63
(m, 1 H, 3-CH), 5.38 (d, J = 5.0
Hz, 1 H, 6-CH).

Figure 1 Natural steroids having C-(20R) configuration

Scheme 1 Reagents and conditions: a) 10% Pd/C, H2, EtOAc, 3.1 bar, 25-30 ˚C, 12 h, 98%; b) hydazine hydrate, Et3N, MeOH, 25-30 ˚C, 4 h, 98%; c) I2, Et3N, THF, 25-30 ˚C, 3 h, 74%; d) Pd(OAc)2 (0.04%) K2CO3, methyl acrylate, DMF, 25-30 ˚C, 12 h, 77%; e) 10% Pd/C (15% by weight), MeOH, TES (excess), 10 min; f) H2, Pd/C, EtOAc, 3.1 bar, 30 ˚C, 10 h (overall 90% after two steps; ratio of 12a/12b = 8:2).

Figure 2 ¹H NMR of epimeric mixture of 11a,b and 12a,b

Figure 3 ¹H NMR of epimeric mixture of 12a and 12b

Figure 4 ORTEP view of methyl (20R)-3β-acetoxychol-5-enoate 12a